MIDAZOLAM IN 0.9% SODIUM CHLORIDE (Midazolam) Patent Expiration, LOE Window & CMS Spending

MIDAZOLAM IN 0.9% SODIUM CHLORIDE (Midazolam) by Inforlife Sa: FDA Orange Book core substance LOE 2038-06-20, 0 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorInforlife Sa
FDA Application & PathwayN211844 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2038-06-20
Last Listed Patent or Exclusivity Date2038-06-20
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel